Skip to main content

Books in Drug adverse reactions and interactions

    • Mechanisms of Drug Toxicity

      • 1st Edition
      • October 22, 2013
      • H. Rašková
      • English
      • Paperback
        9 7 8 1 4 8 3 1 2 4 7 8 0
      • eBook
        9 7 8 1 4 8 3 1 5 7 2 0 7
      Mechanisms of Drug Toxicity, Volume 4 presents the proceedings of the 3rd International Pharmacological Meeting held in Sao Paulo, Brazil in 1966. The book discusses the drug-induced pathobiotic effects; the mechanisms of adverse reactions; and enzyme induction in the mechanism of chronic toxicity. The text also describes the influence of inducing substances on the growth of liver and microsomal electron transport systems; the quantitative aspects of chronic toxicity; and the facts and fallacies in predicting drug effects in human.
    • Advances in Drug Research

      • 1st Edition
      • Volume 18
      • October 22, 2013
      • Bernard Testa
      • English
      • eBook
        9 7 8 1 4 8 3 2 8 7 9 8 0
      Each volume in this distinguished series presents authoritative reviews, both generally, on topics of broad interest in drug research, and specifically, on novel and established therapeutic classes. Acknowledged experts contribute in areas such as drug design, clinical and molecular pharmacology, drug metabolism, and mechanisms of action. Reviewers have consistently praised Advances in Drug Research for its comprehensive and lucid summaries of up-to-date knowledge.
    • Side Effects of Drugs Annual

      • 1st Edition
      • Volume 34
      • December 14, 2012
      • Jeffrey K Aronson
      • English
      • Hardback
        9 7 8 0 4 4 4 5 9 4 9 9 0
      • eBook
        9 7 8 0 4 4 4 5 9 5 0 3 4
      The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading.
    • Therapeutic Drug Monitoring

      • 1st Edition
      • June 7, 2012
      • Amitava Dasgupta
      • English
      • Hardback
        9 7 8 0 1 2 3 8 5 4 6 7 4
      • eBook
        9 7 8 0 1 2 3 8 5 4 6 8 1
      Therapeutic Drug Monitoring: Newer Drugs and Biomarkers features timely topics such as the monitoring of classical and newer drugs, pharmacogenomics and the application of biomarkers in therapeutic drug monitoring. This reference also discusses the limitations of current commercially available immunoassays for therapeutic monitoring. It presents new and sophisticated techniques used for proper determination of blood levels and the clinical utility of therapeutic drug monitoring of contemporary drugs. Written by leading international experts and geared toward clinical pathologists, toxicologists, clinical chemists, laboratory professionals and physicians, this book is an essential resource on the current practice of therapeutic drug monitoring in improving patient safety.
    • Side Effects of Drugs Annual

      • 1st Edition
      • Volume 33
      • November 18, 2011
      • Jeffrey K Aronson
      • English
      • Hardback
        9 7 8 0 4 4 4 5 3 7 4 1 6
      • eBook
        9 7 8 0 4 4 4 5 3 7 4 2 3
      The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading.
    • Histopathology of Preclinical Toxicity Studies

      • 4th Edition
      • October 7, 2011
      • Peter Greaves
      • English
      • Hardback
        9 7 8 0 4 4 4 5 3 8 5 6 7
      • eBook
        9 7 8 0 4 4 4 5 3 8 6 1 1
      The new 4th edition of Histopathology of Preclinical Toxicity Studies is now completely in full color and continues to describe the pathology found in drug safety studies in laboratory animals with an evidence-based discussion of the relevance of these findings to the clinical investigation of new drugs for humans. Organized according to organ systems, this revision features a thoroughly updated bibliography and discusses new drug-induced pathologies and applicable species comparisons to aid in the preclinical safety assessment of new medicines. This updated reference is essential for those involved in drug safety evaluation, including pathologists, toxicologists and pharmacologists working in corporate, government, academic and research settings.
    • Side Effects of Drugs Annual

      • 1st Edition
      • Volume 32
      • November 18, 2010
      • Jeffrey K. Aronson
      • English
      • Hardback
        9 7 8 0 4 4 4 5 3 5 5 0 4
      • eBook
        9 7 8 0 4 4 4 5 3 5 5 1 1
      The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the informative, by critically interpreting it, and by pointing to whatever is misleading.
    • Meyler's Side Effects of Drugs in Cancer and Immunology

      • 1st Edition
      • April 19, 2010
      • Jeffrey K. Aronson
      • English
      • Hardback
        9 7 8 0 4 4 4 5 3 2 6 7 1
      • Paperback
        9 7 8 0 4 4 4 5 6 2 0 6 7
      • eBook
        9 7 8 0 0 8 0 9 3 2 8 8 0
      Elsevier now offers a series of derivative works based on the acclaimed Meyler’s Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. There has been significant progress in the development of targeted therapy drugs that act specifically on certain cancers, and that minimize damage to normal cells. Oncologists and cancer researchers will rely on this volume to determine effective drug treatments.
    • Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs

      • 1st Edition
      • December 16, 2009
      • Jeffrey K. Aronson
      • English
      • Paperback
        9 7 8 0 4 4 4 5 6 2 0 8 1
      • Hardback
        9 7 8 0 4 4 4 5 3 2 7 3 2
      • eBook
        9 7 8 0 0 8 0 9 3 2 9 4 1
      Elsevier now offers a series of derivative works based on the acclaimed Meyler’s Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. Opioids and analgesics are members of a diverse group of drugs used to relieve pain. They are frequently used in combination with prescription and nonprescription pain relievers, and misuse is prevalent. Pain medicine specialists and physicians or surgeons will find this volume useful in prescribing the appropriate drugs for pain therapy and for preventing misuse of the medication.
    • Meyler's Side Effects of Antimicrobial Drugs

      • 1st Edition
      • November 25, 2009
      • Jeffrey K. Aronson
      • English
      • Hardback
        9 7 8 0 4 4 4 5 3 2 7 2 5
      • eBook
        9 7 8 0 0 8 0 9 3 2 9 3 4
      Elsevier now offers a series of derivative works based on the acclaimed Meyler’s Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. This volume is essential for internal medicine physicians and general practitioners who prescribe antibiotic drugs, like penicillin and tetracycline that cure bacterial infections, and antiviral drugs used to treat patients with HIV and herpes viruses.